Joseph Ley
Pediatrics · Kingsport, TNNPI 1689677304
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.1%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.6%. Reporting peaked in 2019 at $4,485 and has fallen 89.3% since, to $479 in 2025. Among pediatrics clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $46.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2K
- Supernus Pharmaceuticals, Inc.$2K
- AstraZeneca$2K
- Merck$1K
- Sanofi Pasteur Inc.$1K
- GSK$748
- plus $982 from 13 others
Across 447 payments — averaging $1888.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$434K
- Pfizer$152K
- Sanofi Pasteur Inc.$110K
- GSK$86K
- Novavax Inc$22K
- AstraZeneca$20K
- plus $21K from 5 others
What the payments were for
- Speaking & faculty fees$450%
- Travel & lodging$4,91048%
- Food & beverage$5,19051%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 21 | $2,399 |
| Supernus Pharmaceuticals, Inc. | 45 | $1,576 |
| AstraZeneca(2 entities) | 14 | $1,528 |
| Merck | 25 | $1,475 |
| Sanofi Pasteur Inc. | 17 | $1,448 |
| GSK | 44 | $748 |
| Tris Pharma Inc | 15 | $259 |
| UCB, Inc. | 6 | $174 |
| Corium, LLC | 6 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $98 |
| Ironshore Pharmaceuticals Inc. | 4 | $77 |
| Kaleo, Inc. | 3 | $42 |
| Sanofi | 2 | $38 |
| Seqirus USA Inc | 2 | $33 |
| Collegium Pharmaceutical, Inc. | 2 | $29 |
| AbbVie | 2 | $27 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NO PRODUCT DISCUSSED$1,140
- V114$990
- QELBREE$546
How this compares
$10,156 in reported general payments places this provider in the 95th percentile of 1,338 pediatrics providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 24 | $530 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Kingsport
- Kimberley HuntKingsport$4K
- Madeline EllisGallatin$134K
- Jason JohnsonMemphis$131K
- Kelly DawsonNashville$40K
- Deanna BrownLebanon$24K
- Lauren JohnsonKnoxville$23K
- Misty EvansNashville$22K
- Amy DempseyMemphis$13K
- Patricia RobinsonMadison$12K
- Anna MoradNashville$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.